Diagnostic Areas

Our early efforts have helped bring the mapping biopsy technique from the research arena to an accepted diagnostic tool that is now a covered procedure by Medicare and most insurance companies. Other examples of our research into diagnostic and predictive modalities include:

• Prostate Cancer Gene 3 (PCA3) - This may help us better determine whether or when a new or repeat biopsy is indicated. [read more]

• Optical biopsies – The use of optical wavelengths of light to sample prostatic tissue and assist in proper disease staging [read more] [ Optical biopsy shines light on prostate cancer ]

• Pro PSA [read more]

• Prostate PX - By taking into account your individual cellular, molecular and clinical information, a more personalized risk assessment of your disease may be made. [read more]

• Endo Rectal MRI - A more sophisticated and sensitive imaging technique for prostate diagnosis and staging. [read more]